{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T17:43:59Z","timestamp":1794591839208,"version":"4.9.1"},"reference-count":15,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.urolonc.2021.12.008","type":"journal-article","created":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T15:59:09Z","timestamp":1644335949000},"page":"196.e11-196.e16","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Does pathological sub stratification of T2 bladder cancer predict outcome in a contemporary pure urothelial carcinoma cohort?"],"prefix":"10.1016","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0950-1296","authenticated-orcid":false,"given":"Isamu","family":"Tachibana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3351-9904","authenticated-orcid":false,"given":"Zain A.","family":"Abedali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandra","family":"Flack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabil","family":"Adra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6049-5293","authenticated-orcid":false,"given":"Liang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hristos Z.","family":"Kaimaklitois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2021.12.008_bib0001","series-title":"AJCC cancer staging manual","author":"Fleming","year":"1997"},{"issue":"2","key":"10.1016\/j.urolonc.2021.12.008_bib0002","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.juro.2008.10.038","article-title":"Comparison of american joint committee on cancer pathological stage T2a versus T2b urothelial carcinoma: analysis of patient outcomes in organ confined bladder cancer","volume":"181","author":"Boudreaux","year":"2009","journal-title":"J Urol"},{"issue":"12","key":"10.1016\/j.urolonc.2021.12.008_bib0003","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1002\/(SICI)1097-0142(19990615)85:12<2638::AID-CNCR21>3.0.CO;2-V","article-title":"Tumor size predicts the survival of patients with pathologic stage T2 bladder carcinoma: a critical evaluation of the depth of muscle invasion","volume":"85","author":"Cheng","year":"1999","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.urolonc.2021.12.008_bib0004","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/j.1464-410X.2010.09548.x","article-title":"Comparison of the new American Joint Committee on Cancer substratification in node-negative pT2 urothelial carcinoma of the bladder: analysis of patient outcomes in a contemporary series","volume":"107","author":"Gakis","year":"2011","journal-title":"BJU Int"},{"issue":"6","key":"10.1016\/j.urolonc.2021.12.008_bib0005","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1590\/S1677-55382007000600005","article-title":"Pathological staging of muscle invasive bladder cancer. Is substaging of pT2 tumors really necessary?","volume":"33","author":"Tokgoz","year":"2007","journal-title":"Int Braz J Urol"},{"issue":"2","key":"10.1016\/j.urolonc.2021.12.008_bib0006","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.juro.2006.03.065","article-title":"Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy","volume":"176","author":"Yu","year":"2006","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.urolonc.2021.12.008_bib0007","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.eururo.2010.01.015","article-title":"Validation of the AJCC TNM substaging of pT2 bladder cancer: deep muscle invasion is associated with significantly worse outcome","volume":"58","author":"Tilki","year":"2010","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.urolonc.2021.12.008_bib0008","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1016\/j.juro.2012.07.035","article-title":"Prognostic significance of measured depth of invasion of urothelial carcinoma of the bladder compared to the 2010 American Joint Committee on Cancer pT2 and pT3 classifications","volume":"188","author":"Zarei","year":"2012","journal-title":"J Urol"},{"issue":"2","key":"10.1016\/j.urolonc.2021.12.008_bib0009","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"Journal of biomedical informatics"},{"issue":"3","key":"10.1016\/j.urolonc.2021.12.008_bib0010","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/bju.14704","article-title":"The impact of non-urothelial variant histology on oncological outcomes following radical cystectomy","volume":"124","author":"Stroman","year":"2019","journal-title":"BJU Int"},{"issue":"1","key":"10.1016\/j.urolonc.2021.12.008_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2014.10.001","article-title":"Contemporary bladder cancer: variant histology may be a significant driver of disease","volume":"33","author":"Monn","year":"2015","journal-title":"Urol Oncol"},{"issue":"6","key":"10.1016\/j.urolonc.2021.12.008_bib0012","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.urolonc.2018.03.018","article-title":"A systematic review and meta-analysis of lymphovascular invasion in patients treated with radical cystectomy for bladder cancer","volume":"36","author":"Mari","year":"2018","journal-title":"Urol Oncol"},{"issue":"2","key":"10.1016\/j.urolonc.2021.12.008_bib0013","doi-asserted-by":"crossref","first-page":"e89259","DOI":"10.1371\/journal.pone.0089259","article-title":"Prognostic significance of lymphovascular invasion in radical cystectomy on patients with bladder cancer: a systematic review and meta-analysis","volume":"9","author":"Kim","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.urolonc.2021.12.008_bib0014","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.juro.2018.05.162","article-title":"Prognostic Value of Concomitant Carcinoma In Situ in the Radical Cystectomy Specimen: A Systematic Review and Meta-Analysis","volume":"201","author":"Kimura","year":"2019","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.urolonc.2021.12.008_bib0015","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00345-019-02738-2","article-title":"Concomitant carcinoma in situ may not be a prognostic factor for patients with bladder cancer following radical cystectomy: a PRISMA-compliant systematic review and meta-analysis","volume":"38","author":"Zhang","year":"2020","journal-title":"World J Urol"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143921005561?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143921005561?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:24:48Z","timestamp":1761042288000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143921005561"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S1078143921005561"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2021.12.008","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Does pathological sub stratification of T2 bladder cancer predict outcome in a contemporary pure urothelial carcinoma cohort?","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2021.12.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}